Hanil Pharm seeking to normalize management

Published: 2004-03-16 06:58:00

Updated: 2004-03-16 06:58:00

Hanil Pharm, which has been under composition from creditors, said on March 11 that it is now seeking for normalization of its business operation to shorten an earlier termination of the composition, as the company entered into an agreement with CJ Corporation and KDB & Partners, main creditor, w...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK